- 专利标题: PHARMACEUTICAL COMPOSITION AND APPLICATION REPLACING QUINOLONE DERIVATIVE, PHARMACEUTICAL ACCEPTABLE SALT, OR STEREOISOMER
-
申请号: EP16836661.5申请日: 2016-08-18
-
公开(公告)号: EP3339294A1公开(公告)日: 2018-06-27
- 发明人: DING, Ke , GENG, Meiyu , TAN, Li , DING, Jian , ZHANG, Zhang , AI, Jing , REN, Xiaomei , GAO, Donglin , TU, Zhengchao , LU, Xiaoyun , ZHANG, Dongmei
- 申请人: Jinan University , Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- 申请人地址: 601 Huangpu Avenue West Tianhe District Guangzhou Guangdong 510632 CN
- 专利权人: Jinan University,Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- 当前专利权人: Jinan University,Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- 当前专利权人地址: 601 Huangpu Avenue West Tianhe District Guangzhou Guangdong 510632 CN
- 代理机构: Ström & Gulliksson AB
- 优先权: CN201510509618 20150818
- 国际公布: WO2017028797 20170223
- 主分类号: C07D215/233
- IPC分类号: C07D215/233 ; C07D487/04 ; C07D401/12 ; A61K31/4709 ; A61P35/00
摘要:
Provided are a substituted quinolone derivative as shown by formula (I), or a pharmaceutically acceptable salt and a prodrug molecule thereof, and a pharmaceutical composition thereof, as well as the use of same in preparing drugs for the prevention and treatment of a tumor. The quinolone derivative, salt, prodrug molecule, and pharmaceutical composition thereof can be used as a protein kinase inhibitor, which is effective in inhibiting the activity of AXL protein kinase, and is capable of inhibiting the proliferation, migration and invasion of various tumor cells; and can be used in the preparation of anti-tumor drugs, especially drugs for treating hyperproliferative diseases such as a tumor in human beings and other mammals.
公开/授权文献
信息查询